Northwest Biotherapeutics Inc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.06M0.01M0.01M0.77M0.81M1.45M1.74M0.62M0.34M0.41M2.41M1.29M1.00M1.68M1.93M1.38M
Gross Profit 1.06M0.01M0.01M0.77M0.81M1.45M1.74M0.62M0.34M0.41M2.41M1.29M1.00M1.68M1.93M1.38M
Operating items
Depreciation & Amortization - Total 0.01M
Research & Development 66.91M9.90M13.45M28.91M43.91M85.64M103.12M60.08M33.52M18.15M14.11M33.64M20.31M35.51M27.73M34.89M
Selling, General & Administrative 56.53M5.46M13.34M15.68M12.38M16.96M18.33M10.87M12.46M22.51M16.28M54.26M33.40M33.35M29.71M33.00M
Other Operating Expenses 6.07M0.00M0.01M0.01M-0.01M6.58M8.94M9.04M4.50M
Operating Expenses 129.51M15.36M26.80M44.60M56.28M102.60M128.02M79.89M55.01M45.17M30.39M87.90M53.71M68.86M57.44M67.89M
Operating Income -15.35M-26.79M-43.83M-55.47M-101.14M-126.28M-79.27M-54.68M-41.48M-27.98M-86.61M-52.70M-67.18M-55.51M-66.51M
EBIT -15.35M-26.79M-43.83M-55.47M-101.14M-126.28M-79.27M-54.68M-41.48M-27.98M-86.61M-52.70M-67.18M-55.51M-66.51M
Non-operating items
Non Operating Investment Income 0.05M0.73M0.60M-5.68M
Interest & Investment Income 1.22M0.49M
Other Non Operating Income 0.05M0.60M1.16M-15.06M15.68M17.89M-18.46M18.30M11.83M-443.22M239.35M-37.85M-7.09M-17.27M
Non Operating Income -18.46M5.69M7.17M-443.22M231.83M-37.85M-7.09M-17.27M
Net income details
EBT -22.75M-34.44M-57.27M-56.32M-102.14M-130.44M-83.08M-60.22M-51.35M-30.95M-95.15M-57.71M-73.25M-60.75M-74.28M
Profit After Tax -146.77M-27.37M-32.83M-67.32M-65.79M-135.63M-114.74M-80.21M-73.14M-35.79M-20.81M-529.82M179.13M-105.03M-62.60M-83.78M
Investment Income 0.00M-0.19M
Income from Continuing Operations -22.75M-34.44M-57.27M-56.32M-102.14M-130.44M-83.08M-60.22M-51.35M-30.95M-95.15M-57.71M-73.25M-60.75M-74.28M
Consolidated Net Income -22.75M-34.44M-57.27M-56.32M-102.14M-130.44M-83.08M-60.22M-51.35M-30.95M-95.15M-57.71M-73.25M-60.75M-74.28M
Income towards Parent Company -22.75M-34.44M-57.27M-56.32M-102.14M-130.44M-83.08M-60.22M-51.35M-30.95M-95.15M-57.71M-73.25M-60.75M-74.28M
Net Income towards Common Stockholders -27.37M-32.83M-67.32M-65.79M-102.14M-114.74M-85.86M-74.41M-53.56M-20.81M-529.82M179.13M-105.03M-64.37M-85.19M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.03M0.03M0.03M0.07M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 3.63M4.50M6.36M24.76M38.51M62.22M92.36M123.69M315.86M513.36M597.06M731.50M927.78M1052.85M1153.85M1297.45M
Shares Outstanding (Diluted Average) 0.56M0.73M1.01M1.02M1.12M1.24M
EBITDA -15.35M-26.79M-43.83M-55.47M-101.13M-126.28M-79.27M-54.68M-41.48M-27.98M-86.61M-52.70M-67.18M-65.98M-83.69M